// App-Quantinova.ai

TCT-260 : Endovascular Baroreflex Therapy for Heart Failure With Reduced Ejection Fraction: First-in-Human Results

Researchers

Presenter

  • Horst Sievert

Principal Investigators

  • Tamaz Shaburishvili

  • Martin Rothman

  • Gregg Stone

Medical Centers

  • CardioVascular Center Frankfurt CVC, Frankfurt, Germany

  • Vascular Dynamics, Bodega Bay, California, USA

  • Cardiovascular Research Foundation, New York, New York, USA

  • Tbilisi Heart and Vascular Clinic, Tbilisi, Georgia

Locations

  • Germany

  • United States

  • Georgia

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Heart failure with reduced ejection fraction

  • Heart muscle disease

  • Congestive heart failure

Biomarkers

  • N-terminal pro b-type natriuretic peptide

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • First-In-Human

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved